OpenVSafe by OpenVAERS
Search V-safe

6ED-34175-33754

3 vaccinations 13 coded responses 28 check-ins 13 free-text entries 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
850 / AZ
Registered
2021-03-25
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-24
    Dose 1 — Moderna
  2. 2021-03-25
    Registered in v-safe
  3. 2021-03-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-03-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-03-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-03-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-04-14
    Survey response — day 21, dose 1
    MedDRA: Back pain, Polymenorrhoea — Feeling: Good · Be unable to do your normal daily activities
    Free text: Unusual back pain relating to menstruation, and shorter menstrual period.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-04-21
    Dose 2 — Moderna
  9. 2021-04-21
    Survey response — day 0, dose 2
    MedDRA: Emotional disorder, Feeling abnormal — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness
    Free text: Mental fog and increased emotional sensitivity
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-04-22
    Survey response — days 1–6 daily, dose 2
    MedDRA: Affect lability — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Increased emotional sensitivity
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-04-23
    Survey response — days 1–6 daily, dose 2
    MedDRA: Feeling abnormal — Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Free text: Mental fog
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-04-24
    Survey response — days 1–6 daily, dose 2
    MedDRA: Body temperature increased, Injection site warmth — Feeling: Good · Site: Redness, Swelling
    Free text: Elevated temperature around the injection site
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-04-25
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site warmth — Feeling: Good · Site: Redness, Swelling
    Free text: Raised temperature in the area surrounding the injection site
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-04-26
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site warmth — Feeling: Good
    Free text: Raised temperature around injection site, though it's lower than yesterday
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-04-27
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site warmth — Feeling: Good
    Free text: Increased temperature around injection site
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-04-28
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-05-05
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-07-21
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-12-24
    Dose 3 — Moderna
  20. 2021-12-25
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  21. 2021-12-27
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Diarrhea, Abdominal pain
    Adult check-in
  22. 2021-12-28
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  23. 2021-12-29
    Survey response — days 1–6 daily, dose 3
    MedDRA: Injection site warmth — Feeling: Good · Site: Pain, Redness
    Free text: Raised temperature around injection site
    MedDRA releases: 2024-11 · check-in free text available
  24. 2021-12-30
    Survey response — days 1–6 daily, dose 3
    MedDRA: Injection site warmth — Feeling: Good · Site: Redness
    Free text: Raised temperature around injection site
    MedDRA releases: 2024-11 · check-in free text available
  25. 2022-01-01
    Survey response — day 7, dose 3
    MedDRA: Injection site warmth — Feeling: Good · Site: Redness
    Free text: Raised temperature around injection site
    MedDRA releases: 2024-11 · check-in free text available
  26. 2022-01-07
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  27. 2022-01-14
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  28. 2022-01-21
    Survey response — day 28, dose 3
    MedDRA: Heavy menstrual bleeding, Migraine — Feeling: Poor · Be unable to work or attend school
    Free text: Heavier than usual menstrual cycle, immediately followed by a week-long migraine.
    MedDRA releases: 2024-11 · check-in free text available
  29. 2022-01-28
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  30. 2022-02-04
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  31. 2022-03-27
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  32. 2022-06-24
    Survey response — 6 months, dose 3
    MedDRA: Lymph node pain, Lymphadenopathy, Parotid gland enlargement, Salivary gland pain — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: After my booster, a hyperactive lymph node swelled painfully along with my parotid gland on the side I got my booster on.
    MedDRA releases: 2024-11 · check-in free text available
  33. 2022-06-24
    Report sent to call center — 6 months, dose 3
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  34. 2022-06-27
    Call successful
    Participant prefers to complete VAERS report online

Vaccinations

DoseDateManufacturerCo-administered
12021-03-24Moderna
22021-04-21Moderna
32021-12-24Moderna No

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 7 — day 21, dose 1

2021-04-14

Symptoms: Unusual back pain relating to menstruation, and shorter menstrual period.

Release 7 — day 0, dose 2

2021-04-21

Systemic reaction (other): Mental fog and increased emotional sensitivity

Release 7 — days 1–6 daily, dose 2

2021-04-22

Systemic reaction (other): Increased emotional sensitivity

2021-04-23

Systemic reaction (other): Mental fog

2021-04-24

Systemic reaction (other): Elevated temperature around the injection site

2021-04-25

Systemic reaction (other): Raised temperature in the area surrounding the injection site

2021-04-26

Systemic reaction (other): Raised temperature around injection site, though it's lower than yesterday

Release 8 — days 1–6 daily, dose 2

2021-04-27

Systemic reaction (other): Increased temperature around injection site

Release 10 — days 1–6 daily, dose 3

2021-12-29

Systemic reaction (other): Raised temperature around injection site

2021-12-30

Systemic reaction (other): Raised temperature around injection site

Release 10 — day 7, dose 3

2022-01-01

Systemic reaction (other): Raised temperature around injection site

Release 10 — day 28, dose 3

2022-01-21

Symptoms: Heavier than usual menstrual cycle, immediately followed by a week-long migraine.

Release 12 — 6 months, dose 3

2022-06-24

Symptoms: After my booster, a hyperactive lymph node swelled painfully along with my parotid gland on the side I got my booster on.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBack pain ✓ ✓ ✓
SDHeavy menstrual bleeding · · ✓
SDLymph node pain · · ✓
SDLymphadenopathy · · ✓
SDMigraine · · ✓
SDParotid gland enlargement · · ✓
SDPolymenorrhoea ✓ ✓ ✓
SDSalivary gland pain · · ✓
SROAffect lability ✓ ✓ ✓
SROBody temperature increased ✓ ✓ ○
SROEmotional disorder ✓ ✓ ✓
SROFeeling abnormal ✓ ✓ ✓
SROInjection site warmth ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release